PEPG(PEPG)
PEPG
ANALYST COVERAGE6 analysts
BUY
▲ +257.1%upside to target
L $4.00
Med $5.50consensus
H $7.00Key MetricsTTM
Market Cap$99.60M
Revenue TTM—
Net Income TTM—
Free Cash Flow—
Gross Margin—
Operating Margin—
Net Margin—
Return on Equity-59.9%
Return on Assets—
Debt / Equity0.12
Current Ratio14.98
EPS TTM$-1.12
PRICE
Prev Close
1.44
Open
1.41
Day Range1.40 – 1.56
1.40
1.56
52W Range1.01 – 7.80
1.01
7.80
8% of range
VOLUME & SIZE
Avg Volume
1.4M
FUNDAMENTALS
P/E Ratio
-1.1x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
TECHNICAL
RSI (14)
28
Oversold
Upcoming Events
EEarnings Report
Tomorrow
May 23
DEx-Dividend
In 90 days
Aug 20
PDividend Pay
In 131 days
Sep 30
PEPG News
About
No description available.
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Emiko BryantSenior Vice President of HR & Administration
Hayley ParkerSenior Vice President of Global Regulatory Affairs & Quality
James G. McArthurPresident, Chief Executive Officer, Treasurer, Secretary & Director
Kasra KasraianChief Technology Officer
Paul D. StreckExecutive Vice President and Head of Research & Development
Gregory SongExecutive Director & Head of Biometrics
Melissa MichaelsExecutive Director & Head of Regulatory Affairs CMC
Pallavi LonkarVice President & Head of Preclinical
Joseph D. VittiglioChief Business & Legal Officer and Secretary
Noel DonnellyChief Financial Officer